Kaplan–Meier analyses performed by Ishibashi et al., Ramos et al. and He et al. revealed significant associations between tumour HLA-G expression and poor clinical outcome of breast carcinoma patients, while all studies used different HLA-G-detecting mAbs and quantification methods (Table 1) [17,18,19]. This evidence concerns the gene HLA-G and breast carcinoma.